4//SEC Filing
MEADE HARRY 4
Accession 0000908662-09-000260
CIK 0000904973other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 2:05 PM ET
Size
6.3 KB
Accession
0000908662-09-000260
Insider Transaction Report
Form 4
MEADE HARRY
SVP, Transgenic Research
Transactions
- Tax Payment
Common Stock
2009-06-30$2.66/sh−1,165$3,099→ 15,854 total
Holdings
- 5,302(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The shares reported were withheld to pay a tax liability in connection with the vesting of restricted stock units, which units were previously reported on a prior Form 4 filed by Dr. Meade.
- [F2]On May 26, 2009 the issuer effected a one-for-ten reverse stock split of its outstanding common stock, resulting in the reporting person owning 153,193 fewer shares of common stock.
- [F3]On May 26, 2009 the issuer effected a one-for-ten reverse stock split of its outstanding common stock, resulting in the reporting person owning 47,726 fewer shares of common stock in his 401(k).
Documents
Issuer
GTC BIOTHERAPEUTICS INC
CIK 0000904973
Entity typeother
Related Parties
1- filerCIK 0001241322
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 2:05 PM ET
- Size
- 6.3 KB